For the quarter ended December 2024, Sight Sciences, Inc. (SGHT) reported income of $19.07 million, up 1.7% over the identical interval final yr. EPS got here in at -$0.23, in comparison with -$0.22 within the year-ago quarter.
The reported income represents a shock of +0.50% over the Zacks Consensus Estimate of $18.98 million. With the consensus EPS estimate being -$0.20, the EPS shock was -15.00%.
Whereas buyers scrutinize income and earnings adjustments year-over-year and the way they examine with Wall Road expectations to find out their subsequent transfer, some key metrics all the time supply a extra correct image of an organization’s monetary well being.
Since these metrics play an important function in driving the top- and bottom-line numbers, evaluating them with the year-ago numbers and what analysts estimated about them helps buyers higher mission a inventory’s worth efficiency.
Right here is how Sight Sciences carried out within the simply reported quarter by way of the metrics most generally monitored and projected by Wall Road analysts:
- Income- Dry Eye: $0.30 million versus $0.31 million estimated by three analysts on common. In comparison with the year-ago quarter, this quantity represents a -81% change.
- Income- Surgical Glaucoma: $18.77 million versus the three-analyst common estimate of $19.08 million. The reported quantity represents a year-over-year change of +9.4%.
- Gross Revenue – Dry Eye: $0.16 million versus the two-analyst common estimate of $0.02 million.
- Gross Revenue – Surgical Glaucoma: $16.41 million in comparison with the $16.49 million common estimate primarily based on two analysts.
View all Key Company Metrics for Sight Sciences here>>>
Shares of Sight Sciences have returned -11.8% over the previous month versus the Zacks S&P 500 composite’s -4.1% change. The inventory presently has a Zacks Rank #3 (Maintain), indicating that it may carry out according to the broader market within the close to time period.
Zacks Names #1 Semiconductor Inventory
It is just one/9,000th the dimensions of NVIDIA which skyrocketed greater than +800% since we really useful it. NVIDIA continues to be robust, however our new high chip inventory has rather more room to increase.
With robust earnings progress and an increasing buyer base, it is positioned to feed the rampant demand for Synthetic Intelligence, Machine Studying, and Web of Issues. International semiconductor manufacturing is projected to blow up from $452 billion in 2021 to $803 billion by 2028.
See This Stock Now for Free >>
Sight Sciences, Inc. (SGHT) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.
